Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects

Launched by GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE, BANGALORE · Mar 5, 2015

Keywords

ClinConnect Summary

Two groups were made. One was delivered with ATV after SRP, the other was delivered with placebo gel after SRP.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • lower first molars demonstrating a probing pocket depth of 5 mm and horizontal probing depth of 3 mm following phase 1 therapy, with furcation defects (degree II) present bucally in asymptomatic, vital lower first molars, with a furcation radiolucency on a periapical radiograph of the molars.
• Exclusion Criteria:
• • patients with systemic diseases like cardiovascular disease
• • diabetes or HIV infection or on medications like corticosteroids which may impede the healing in periodontal tissues.
• • pregnant/lactating females
• • tobacco users
• • alcoholics
• • patients with unsatisfactory oral hygiene (plaque index greater than 1.5)
• • teeth having gingival recession, caries involving pulp, intrabony defect present interproximally, grade 2/3 mobility
• • Furthermore, patients allergic to ATV or other statins or those taking ATV/other statins systemically were excluded.